Europe
Asia
Oceania
Americas
Africa
FORTUNE
CEO, GSK —U.K.
CITY
In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan
HOW AI IS SUPERCHARGING THE SECTOR
Out of puff: Second-quarter revenue at Connecticut-based Marlboro-maker Philip Morris International (PMI) rose 7.1% from a year earlier, to $10.1bn – slightly short of analysts’ expectations of $10.3b
A DECADE AGO, while L’Oréal stood as the ...